Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Embecta Corp. - Common Stock (NQ:EMBC)

14.14 -0.11 (-0.77%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Embecta Corp. - Common Stock

< Previous 1 2 3 4 Next >
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
Embecta Corp (NASDAQ:EMBC) Surpasses Q3 Earnings Estimates, Shares Jump 10.5% in Pre-Market Trading
Embecta Corp (EMBC) beats Q3 2025 earnings estimates with $295.5M revenue and $1.12 EPS, sparking a 10.5% pre-market stock surge. Strong performance may lift full-year forecasts. 
Via Chartmill
Earnings Scheduled For August 8, 2025
 
Via Benzinga
An Overview of Embecta's Earnings
 
Via Benzinga
A Peek at Embecta's Future Earnings
 
Via Benzinga
Earnings Scheduled For February 6, 2025
 
Via Benzinga
Why Is Embecta Stock Falling On Friday?
Embecta reaffirms earnings outlook, trims revenue forecast, and boosts cash flow as restructuring and cost controls offset tariff and FX headwinds. 
Via Benzinga
Topics World Trade
Earnings Scheduled For May 9, 2025
 
Via Benzinga
Becton Dickinson Q1 Earnings: Revenue And EPS Beat, Lowers Outlook, Outlines Intent To Separate Biosciences And Diagnostic Solutions Business
Becton Dickinson plans to spin off its Biosciences and Diagnostic Solutions unit, targeting a fiscal 2026 completion, while updating FY25 revenue guidance. 
Via Benzinga
Uncovering Potential: Embecta's Earnings Preview
 
Via Benzinga
Embecta Corp. Reports First Quarter Fiscal 2025 Financial Results
From Embecta Corp.
Via GlobeNewswire
embecta Announces Quarterly Cash Dividend
From Embecta Corp.
Via GlobeNewswire
Activist Starboard Value Pushes Becton Dickinson To Divest Life Sciences Unit
Activist investor Starboard Value is urging Becton Dickinson to sell its life sciences division, citing potential value gains. Analysts estimate a spin-off could boost the company's worth by up to... 
Via Benzinga
embecta to Report Fiscal First Quarter 2025 Financial Results
From Embecta Corp.
Via GlobeNewswire
Aehr Test Systems Posts Weak Results, Joins Trump Media & Technology Group And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
 
Via Benzinga
Topics Government
embecta to Participate at the 43rd Annual J.P. Morgan Healthcare Conference
From Embecta Corp.
Via GlobeNewswire
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos
Morgan Stanley upgrades key MedTech stocks, highlighting strong demand and growth potential, while downgrading others amid company-specific challenges. 
Via Benzinga
This Dick's Sporting Goods Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
Crude Oil Moves Lower; Dick's Sporting Goods Earnings Top Views
 
Via Benzinga
Becton Dickinson Spinoff Embecta Stops Insulin Patch Pump Program, Plans Restructuring, Stock Jumps
Embecta reports fourth quarter earnings beating estimates, discontinues insulin patch program, and announces restructuring plans with cost-saving measures. 
Via Benzinga
Nasdaq Rises 100 Points; Abercrombie & Fitch Shares Fall After Q3 Results
 
Via Benzinga
J.M. Smucker Posts Upbeat Earnings, Joins LexinFintech, Semtech, Arrowhead Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday
 
Via Benzinga
Embecta Corp. Reports Fiscal 2024 Fourth Quarter and Full Year Financial Results; Provides Initial Fiscal Year 2025 Financial Guidance; Discontinues Insulin Patch Pump Program; and Announces Restructuring to Streamline Operations and Reduce Costs
From Embecta Corp.
Via GlobeNewswire
embecta Announces Quarterly Cash Dividend
From Embecta Corp.
Via GlobeNewswire
Earnings Scheduled For November 26, 2024
 
Via Benzinga
UPDATE - embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results
From Embecta Corp.
Via GlobeNewswire
embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results
From Embecta Corp.
Via GlobeNewswire
embecta Celebrates National Diabetes Awareness Month by Ringing Nasdaq Closing Bell
Advocacy and professional groups join global diabetes care company at Nasdaq to raise awareness of diabetes, while also commemorating the company’s 100-year legacy of serving this community 
From Embecta Corp.
Via GlobeNewswire
embecta Announces FDA Clearance of its Disposable Patch Pump for Insulin Delivery Informed by the Unique Needs of People with Type 2 Diabetes
From Embecta Corp.
Via GlobeNewswire
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.